Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondriaSaroj P. Mathupala, Peter L. Pedersen, Young Hee Ko|Oncogene|2006Cited by 756
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapySaroj P. Mathupala, Peter L. Pedersen, Young Hee Ko|Seminars in Cancer Biology|2008Cited by 585
Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L. Pedersen, Young Hee Ko, Saroj P. Mathupala et al.|Biochimica et Biophysica Acta (BBA) - Bioenergetics|2002Cited by 350
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATPYoung Hee Ko, Peter L. Pedersen, Barbara L. Smith et al.|Biochemical and Biophysical Research Communications|2004Cited by 350
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinaseYoung Hee Ko, J.F. Geschwind, Peter L. Pedersen|Cancer Letters|2001Cited by 346